Objectives: Colistin susceptibility in Pseudomonas aeruginosa is associated with a lipopolysaccharide (LPS) structure that is controlled by the modulation of several two-component regulatory systems. In this study, we attempted to elucidate the role of these two-component systems in the development of colistin resistance in P. aeruginosa.
Introduction
Pseudomonas aeruginosa is a major cause of pneumonia, urinary tract infections, surgical site infections and bloodstream infections. 1 P. aeruginosa has the ability to develop resistance to multiple classes of antimicrobial agents, provoking the emergence of multidrug-resistant (MDR) isolates. 2 The emergence and spread of MDR Gram-negative bacteria, including P. aeruginosa, has led to the resurgent use of polymyxin antibiotics such as polymyxin B and colistin as therapeutic agents. In turn, the increased use of polymyxin treatment has resulted in the occurrence of polymyxinresistant P. aeruginosa isolates around the world. 3 -6 Thus far, the mechanism of polymyxin resistance has been found to involve a reduced negative charge on the bacterial outer membrane, which results from specific modification of the lipid A component of the lipopolysaccharide (LPS). The arnBCADTEFpmrE (pmrHFIJKLME) operon encodes enzymes responsible for the biosynthesis and attachment of 4-amino-4-deoxy-L-arabinose (L-Ara4N) to lipid A, resulting in polymyxin resistance. 7, 8 In P. aeruginosa, both the PhoPQ and PmrAB two-component regulatory systems respond to Mg 2+ -limiting conditions, resulting in overexpression of the arnB operon, and are involved in polymyxin B adaptation and inducible resistance in P. aeruginosa clinical isolates. 8, 9 Alterations in these PmrAB and PhoPQ two-component systems caused by specific mutations are known to contribute to high-level resistance in clinical strains of P. aeruginosa. 10, 11 Recently, ParRS and CprRS two-component regulatory systems have also been found to play a role in polymyxin resistance in P. aeruginosa. 12 -14 Although involvement of the PmrAB, PhoPQ, ParRS and CprRS two-component systems in polymyxin resistance is known in P. aeruginosa, the contribution of the two-component regulatory systems to polymyxin resistance remains unclear.
In this study, we obtained high-level colistin-resistant mutants from pmrA-, phoP-, parR-and cprR-inactivated mutants by continuous exposure to colistin. Amino acid alterations in PmrAB, PhoPQ, ParRS and CprRS and expression levels of the pmrA, phoP, parR, cprR and arnB genes were compared between a colistin-susceptible wild-type P5 strain, its gene-inactivated mutants and in vitro-selected colistin-resistant mutants. We showed that acquisition of colistin resistance in these mutants is associated mainly with the PhoPQ two-component regulatory system resulting in up-regulation of the arnB operon. However, colistin resistance is not entirely dependent on PmrAB, PhoPQ, ParRS or CprRS in P. aeruginosa and could arise by alternative or compensatory pathways even if one of these major twocomponent systems is inactivated.
Materials and methods

Bacterial strains, plasmids and culture conditions
All bacterial strains and plasmids used for development of resistance to colistin and specific gene inactivation in this study are listed in Table S1 (available as Supplementary data at JAC Online). The colistin-susceptible P. aeruginosa clinical isolate P5 was used as a parental strain. 6 Induced colistin-resistant mutant P5R, derived from P5, was made for our previous study. 15 Bacteria were routinely grown in Luria-Bertani (LB) broth or agar at 378C, with the exception of the P5 harbouring plasmid pHK1014 (308C). The concentrations of antibiotics used for selection and maintenance of transformants were 50 mg/L gentamicin for Escherichia coli and 400 mg/L kanamycin and 50 mg/L gentamicin for P. aeruginosa.
Construction of deletion mutants for target genes
To construct pmrA-, phoP-, parR-or cprR-inactivated mutants (P5DpmrA, P5DphoP, P5DparR and P5DcprR, respectively) from the colistin-susceptible P5 strain, which was characterized in our previous study, 6 allelic replacement mutagenesis was performed with minor modifications as described previously. 16 Briefly, 500 bp chromosomal DNA segments containing left and right regions of the target genes were PCR amplified from chromosomal DNA using specific oligonucleotide primers (Table S2 , available as Supplementary data at JAC Online). Reverse primers for left fragments and forward primers for right fragments were designed to contain 20 nucleotides that are identical to the 5 ′ -and 3 ′ -regions of the cassette. Ultimately, a constructed fusion PCR fragment replaced part of the target gene with a cassette gene. For replacement of the target gene and selection of gene-inactivated mutants, we used a kanamycin resistance gene cassette (904 bp) containing the aphIII gene and its promoter region, which was amplified from Enterococcus faecalis ATCC 51299 chromosomal DNA. After the two-step PCR, the resulting fusion PCR products (.500 ng/mL) were directly transformed into competent cells harbouring helper plasmid pHK1014, which has the aacC1 gene and the origin of replication from pUCP18, 17 and the lRed recombinase functions for stimulation of homologous recombination from pKD46. 18 Homologous recombination between the construct and target gene in the chromosome was forced using a chemical transformation method. 19 Kanamycin-resistant transformants were selected on LB agar plates supplemented with 400 mg/L kanamycin. Targeted gene replacement events were confirmed by colony PCR. Cell lysates from mutant strains were used as PCR templates along with primers L-F and R-R to verify the correct incorporation of the gene replacement construct into the genome. The correct incorporation of the fused construct results in a larger or smaller PCR product ( 1.8 kb) obtained from the mutant strain compared with that of the wildtype strain.
In vitro selection of induced colistin-resistant mutants
Colistin-resistant mutants were acquired in vitro from a wild-type strain P5 and the four gene-inactivated mutants P5DpmrA, P5DphoP, P5DparR and P5DcprR. They were designated P5R, P5DpmrA-R, P5DphoP-R, P5DparR-R and P5DcprR-R, respectively. Development of colistin resistance was performed via serial passage through increasing concentrations of colistin in LB broth. Briefly, 10 6 cfu/mL from overnight cultures of colistinsusceptible strains was inoculated into LB medium without colistin and incubated overnight with vigorous shaking at 378C. These overnight cultures of colistin-susceptible isolates were diluted 1: 100 into fresh medium containing a subinhibitory concentration of colistin (0.25 mg/L) and incubated overnight. Then, serial daily passages in LB broth with increasing concentrations of colistin (from 0.5 to 16 mg/L) were performed sequentially on in vitro-selected mutants at the stage just before. The rate of resistance development was determined by scoring the number of colonies with reduced susceptibility to colistin at the early stage (a passage from 0.5 to 1 mg/L colistin). At the end of the development period, spontaneous mutants grown in LB broth containing 16 mg/L colistin were selected again on LB agar plates containing 32 mg/L colistin. MICs of colistin for three colonies picked at random were confirmed.
In vitro antimicrobial susceptibility testing
In vitro antimicrobial susceptibility testing was performed by a broth microdilution method according to CLSI guidelines. 20 Eleven antimicrobial agents were tested: colistin sulphate, polymyxin B, imipenem, piperacillin/ tazobactam, ampicillin/sulbactam, cefepime, ceftriaxone, ceftazidime, tetracycline, ciprofloxacin and amikacin. Susceptibility was defined according to CLSI breakpoints. E. coli ATCC 25922 and P. aeruginosa ATCC 27853 were employed as reference strains. All tests were repeated with three independent cultures, each tested in duplicate.
Sequencing of pmrAB, phoPQ, parRS and cprRS genes
Full-length pmrAB, phoPQ, parRS and cprRS were sequenced using the primers listed in Table S2 . Previously published primers for pmrAB and phoPQ were used in this study. 15 Primers for parRS and cprRS were designed using the Primer 3 online software (http://frodo.wi.mit.edu/primer3/). The sequences were analysed using DNAStar software (DNAStar Inc., Madison, WI, USA). Amino acid sequences of wild-type P5, gene-inactivated mutants and their induced colistin-resistant mutants were compared with those of P. aeruginosa reference strain PAO1 (GenBank accession number AE004091.2). To predict whether amino acid substitutions in PmrAB, PhoPQ, ParRS and CprRS affect protein function, sorting intolerant from tolerant (SIFT) scores were calculated (http://sift.jcvi.org). Additionally, we performed SMART analysis (http://smart.embl.de/) for the determination of domain architectures in PmrA, PmrB, PhoP, PhoQ, ParR, ParS, CprR and CprS.
Quantitative RT-PCR (qRT-PCR)
Expression levels of the pmrA, phoP, parR, cprR and arnB genes were determined by qRT-PCR as described previously with some modifications. 21, 22 Quantification of pmrA, phoP, parR, cprR and arnB transcripts was performed using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on the ABI7300 Sequence Detection System (Applied Biosystems) with primers designed for this study using Primer 3 (Table S2 ). The expression levels for target genes were analysed by the comparative CT method and expression of the 30S ribosomal gene rpsL was assessed in parallel to normalize the transcriptional levels of target genes. Experiments were repeated with three independent cultures, Colistin resistance in P. aeruginosa 2967 JAC each tested in duplicate. The results are presented as means and standard deviations of six replicate experiments. When the expression of genes is different by .2-fold, the relative value of expression is defined as significant.
Results
Development of colistin resistance in pmrA-, phoP-, parR-or cprR-inactivated mutants
To investigate the impact of the PmrAB, PhoPQ, ParRS and CprRS two-component regulatory systems on adaptive resistance to colistin, we constructed gene-inactivated mutants of the pmrA, phoP, parR and cprR genes from colistin-susceptible clinical isolate P5 and attempted to induce colistin resistance from these mutants. In vitro-selected colistin-resistant mutants were obtained from all gene-inactivated mutants, just like from wild-type P5. These colistin-resistant mutants derived from P5DpmrA, P5DphoP, P5DparR and P5DcprR were designated P5DpmrA-R, P5DphoP-R, P5DparR-R and P5DcprR-R, respectively. All colistin-resistant mutants exhibited complete colistin resistance phenotypes showing MICs of ≥256 mg/L ( Table 1 ). The rates of resistance development to colistin in P5DpmrA, P5DphoP, P5DparR and P5DcprR were lower than that for wild-type P5. In particular, at the early stage (a passage from 0.5 to 1 mg/L colistin) of resistance development, the development rate was highest in P5 (2.2×10
21
) and lowest in P5DpmrA (1.04×10
23
). The rates of resistance development in P5DphoP, P5DcprR and P5DparR were 1.22×10
22 , 2.94×10 22 and 1.02×10 21 , respectively. However, development rates were not different significantly among the mutant strains at colistin concentrations .1 mg/L. Table 1 also lists the susceptibility of wild-type P5, gene-inactivated mutants and induced colistin-resistant mutants to several antimicrobial agents, including colistin and polymyxin B. The pmrA-inactivated mutant, P5DpmrA, showed slightly decreased MICs of colistin and polymyxin B (0.5 and 0.25 mg/L, respectively) compared with the colistin-susceptible P5 wild-type strain. However, MICs of colistin and polymyxin B for the phoP-, parRor cprR-inactivated mutants (P5DphoP, P5DparR and P5DcprR) did not decrease (Table 1) . Rather, P5DphoP showed a slightly increased colistin MIC (2 mg/L). All induced colistin-resistant strains (P5R, P5DpmrA-R, P5DphoP-R, P5DparR-R and P5DcprR-R) showed consistently increased susceptibility to imipenem, piperacillin/tazobactam and tetracycline. Changes in susceptibility to ciprofloxacin, cefepime, ceftriaxone, ceftazidime and amikacin were not observed.
Amino acid variations in PmrAB, PhoPQ, ParRS and CprRS of the in vitro-selected colistin-resistant mutants
To determine whether specific mutations confer colistin resistance in these in vitro-selected colistin-resistant mutants derived from wild-type P5 and the gene-inactivated mutants, 2100 bp sequences of pmrAB, 2025 bp of phoPQ, 1996 bp of parRS and 2144 bp of cprRS were analysed and compared with those of wildtype strain P5. Because we selected repeatedly in vitro-selected mutants at each serial passage, the sequence variations would be accumulated in the final colistin-resistant mutants. Nucleotide variations were found in 7 sites of the pmrA gene, 17 sites of the pmrB gene, 10 sites of the phoQ gene, 4 sites of the parR gene, 11 sites of the parS gene and 2 sites of the cprS gene. Most nucleotide substitutions were synonymous and amino acid alterations identified in colistin-resistant mutants only were found in three sites of PhoQ and three sites of ParS (Table 2) . No amino acid substitutions were found in PmrA, PmrB, PhoP, ParR, CprR and CprS. Among these six alterations, Val260Gly of PhoQ and His398Arg of ParS were predicted to be deleterious to protein function by SIFT score analysis (scores of 0.01 and ,0.01, respectively). Val260Gly of PhoQ and His398Arg of ParS were identified in important functional domains (the histidine kinase domain and histidine kinase- Lee et al.
like ATPase, respectively) of the sensor proteins in P5R. This result suggests the possibility that these amino acid alterations in ParS and PhoQ might have occurred under external stress such as colistin and have an impact on the emergence of colistin resistance.
Expression of the pmrA, phoP, parR, cprR and arnB genes
The arnB gene, which is associated with biosynthesis and attachment of L-Ara4N to lipid A, was overexpressed (2.03-to 4.3-fold) in all in vitro-selected colistin-resistant mutants compared with the colistin-susceptible wild-type and all gene-inactivated mutants (Figure 1) . A non-inactivated in vitro-selected colistin-resistant mutant, P5R, showed elevated expression of the pmrA and phoP genes (2.8-and 21.0-fold, respectively) compared with its colistinsusceptible parent strain P5, but not parR and cprR. While
P5DpmrA-R showed highly elevated expression of the phoP gene (11.9-fold), the expression levels of the parR and cprR genes were not any different from P5DpmrA, as observed in P5R. P5DparR-R and P5DcprR-R also exhibited higher expression of the phoP gene only (11.4-and 15.6-fold, respectively) than their parent strains (P5DparR and P5DcprR, respectively), but the expression levels of the pmrA gene in these strains were increased slightly. The expression of the parR and cprR genes was only marginally increased in all in vitro-selected colistin-resistant mutants.
Discussion
In this study, we generated targeted gene-inactivated mutants of the response regulator genes from colistin-susceptible clinical 
The predicted domains are indicated as follows: unknown, unknown domain; HisKA, histidine kinase A (phosphoacceptor) domain; and HATPase, histidine kinase-like ATPase. Only domains displaying substitutions are shown. 
P5DcprR-R Figure 1 . Expression levels of the pmrA, phoP, parR, cprR and arnB genes in wild-type strain P5, the pmrA-, phoP-, parR-or cprR-inactivated mutants (P5DpmrA, P5DphoP, P5DparR and P5DcprR) and their induced colistin-resistant mutants (P5R, P5DpmrA-R, P5DphoP-R, P5DparR-R and P5DcprR-R). Error bars represent the standard deviations of three biological replicates, each performed in duplicate.
Colistin resistance in P. aeruginosa 2969 JAC isolate P5 to investigate the effect of these two-component systems on adaptive resistance to colistin and lipid A modification through up-regulation of the arnB operon. Among the gene-inactivated mutants, only the pmrA-inactivated mutant showed a 2-and 4-fold decrease in MICs of colistin and polymyxin B, respectively. However, the susceptibility to colistin in the phoP-, parR-or cprR-inactivated mutants did not increase (Table 1 ). In addition, expression levels of the arnB gene in gene-inactivated mutants were similar to that of wild-type P5 (Figure 1 ). That is, inactivation of an individual gene, such as pmrA, phoP, parR or cprR, in various two-component systems did not greatly affect expression levels of the arnB gene, resulting in lipid A modification, in this colistin-susceptible strain. To investigate the indispensability of PmrAB, PhoPQ, ParRS or CprRS for adaptive resistance to colistin, we performed development of colistin resistance from pmrA-, phoP-, parR-or cprR-inactivated mutants and have shown that high-level colistin-resistant mutants can be generated from these gene-inactivated mutants by continuous exposure to colistin. Thus, it can be inferred that when one of the twocomponent regulatory systems associated with colistin resistance does not function, other systems may compensate for it in response to colistin. Occurrence of colistin resistance in all gene-inactivated mutants may be associated with LPS modification, which is known to be regulated by the arnB operon. In P. aeruginosa, the PmrAB, PhoPQ, ParRS and CprRS two-component regulatory systems stimulate transcription of the arnB operon in response to antimicrobial peptide exposure or divalent cation depletion. 12, 14, 23, 24 However, adaptation to colistin in the pmrA-, phoP-, parR-or cprR-inactivated mutants by serial passage in colistin-containing media was successfully accomplished and expression levels of the arnB gene in all in vitro-selected colistinresistant mutants were highly increased. However, P5DparR-R, selected from the parR-inactivated mutant, does not have any amino acid changes in all four two-component regulatory systems. These results suggest that there are alternative pathways to regulate colistin susceptibility related to the arnB operon, in addition to well-known two-component systems such as PmrAB, PhoPQ, ParRS or CprRS. Colistin resistance related to LPS modification in P. aeruginosa may not be entirely dependent on one of the two-component regulatory systems.
The role of PmrAB, ParRS and CprRS two-component systems can be compensated by other mechanisms involved in the colistin resistance of our parent strain P5, because no significant differences in expression levels of the pmrA, parR and cprR genes could be found among the wild-type strain, gene-inactivated mutants or in vitroselected colistin-resistant mutants. Instead, overexpression of the phoP gene was seen in all colistin-resistant mutants, except for the phoP-inactivated strains. Thus, it is most plausible that the PhoPQ two-component system was overexpressed by stimulation of a subinhibitory concentration of colistin and the overexpressed phoP stimulates the arnB operon, which in turn leads to LPS modification and, finally, development of colistin resistance.
The development of colistin resistance in P5DphoP-R should be examined for other possible mechanisms, because overexpression of the pmrA, parR and cprR genes was not seen. In addition, increased expression of the arnB gene was modest compared with that caused by a low concentration of Mg 2+ or peptide treatment. 24 Thus, alternative or compensatory pathways that regulate LPS modification and colistin resistance likely play a role in the phoP-inactivated mutant. The other changes to lipid A besides modification with aminoarabinose or other determinants that affect cell surface structure may modulate colistin resistance. 25 Recently, the ColRS two-component regulatory system was suggested to contribute to colistin resistance in P. aeruginosa. 26 In addition, increased levels of the outer-membrane protein H1 may also be related to polymyxin resistance by replacing Mg 2+ or Ca 2+ in P. aeruginosa. 27 Additionally, high-throughput screening using whole-genome sequencing or screening of transposon mutant libraries of colistin-susceptible and colistin-resistant isolates showed the possibility that diverse genes can be involved in colistin resistance in P. aeruginosa and other Gram-negative bacteria. 25, 28 Thus, further studies should be performed to reach a comprehensive understanding of colistin resistance.
In summary, colistin resistance can be developed in pmrA-, phoP-, parR-and cprR-inactivated mutants as in wild-type P5 through continuous exposure to subinhibitory concentrations of colistin. This finding suggests that individual two-component systems may not be essential in the acquisition of colistin resistance in P. aeruginosa. The PhoPQ two-component system may play a major role in the development of colistin resistance in this study, but colistin resistance in P5DphoP-R mutants suggests alternative or compensatory pathways in the development of colistin resistance.
